Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Fennell

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Poultry Science|June 1, 1996
The suppressive effects of testosterone on growth in young chickens appears to be mediated via a peripheral androgen receptor; studies of the anti-androgen ICI 176,334M J Fennell, S V Radecki, J A Proudman, et al.
Molecular Therapy. Oncology|July 24, 2024
Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastomaMorrent Thang, Clara Mellows, Lauren E Kass, et al.
Frontiers in Pharmacology|April 17, 2023
Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancerEmily M J Fennell, Lucas J Aponte-Collazo, Wimal Pathmasiri, et al.
Cancer Research Communications|November 17, 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial HomeostasisYoshimi Endo Greer, Lidia Hernandez, Emily M J Fennell, et al.
Pharmacology Research & Perspectives|August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpPEmily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
ACS Chemical Biology|July 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues"Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
Research Square|December 3, 2025
Small Molecule Activators of the Mitochondrial Protease ClpP Induce Senescence in Triple-Negative Breast Cancer Cells and Sensitize Cells to the Bcl-2 Inhibitor VenetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Poultry Science|June 1, 1996
The suppressive effects of testosterone on growth in young chickens appears to be mediated via a peripheral androgen receptor; studies of the anti-androgen ICI 176,334M J Fennell, S V Radecki, J A Proudman, et al.
Molecular Therapy. Oncology|July 24, 2024
Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastomaMorrent Thang, Clara Mellows, Lauren E Kass, et al.
Frontiers in Pharmacology|April 17, 2023
Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancerEmily M J Fennell, Lucas J Aponte-Collazo, Wimal Pathmasiri, et al.
Cancer Research Communications|November 17, 2022
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial HomeostasisYoshimi Endo Greer, Lidia Hernandez, Emily M J Fennell, et al.
Pharmacology Research & Perspectives|August 5, 2022
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpPEmily M J Fennell, Lucas J Aponte-Collazo, Joshua D Wynn, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
ACS Chemical Biology|July 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues"Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
Research Square|December 3, 2025
Small Molecule Activators of the Mitochondrial Protease ClpP Induce Senescence in Triple-Negative Breast Cancer Cells and Sensitize Cells to the Bcl-2 Inhibitor VenetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Cell Death & Disease|June 29, 2026
Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclaxSabrina C D Daglish, Owen G Canterbury, Paul R Graves, et al.
Pageof 2